Posted on 18th July 202013th June 2021 by Dr.S.Harsha VardhanDifferential Benefit of Adjuvant Docetaxel Based Chemotherapy in Patients With Early Breast Cancer According to Baseline BMI Share The Content : (Refresh the page or download this document incase the PDF doesn’t load properly) Download This Document Source : ASCO Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on Telegram (Opens in new window) Telegram Share on WhatsApp (Opens in new window) WhatsApp Like this:Like Loading... Related Share The Content :
